You Searched For "pharmaceutical firm bharat biotech" and got 20 results
Sort By:
2 mins read
A biotech firm founded by Vivek Ramaswamy turned $15 million into $5 billion by flipping a bowel-disease treatment that Pfizer gave it for free
Pfizer will still benefit from the 25% stake it retained as well as full rights to the drug outside…
Filip De Mott
1 min read
Concord Biotech IPO to open on August 4; price band at ₹705-741/ share
Rare Enterprises-backed Concord Biotech on Monday said it has fixed a price band of Rs 705-741 a sh…
PTI
2 mins read
Biological E, Bharat Biotech together sitting on stockpile of 250 million COVID vaccine doses
stockpile of 50 million doses of Covaxin. Dr Vikram Paradkar, Executive Vice President (M…
PTI
1 min read
Bharat Biotech applies for emergency use approval for its COVID-19 vaccine Covaxin
Covaxin is being indigenously developed by Bharat Biotech in collaboration with the Indian Coun…
PTI
1 min read
Brazil suspends Covaxin trials, weeks after graft allegations surfaced
The termination of the pact comes after the deal with the Brazilian government for supply of 20 …
PTI
1 min read
Bharat Biotech working on TB vaccine, to ink pact with a firm for technology
"Our honourable Prime Minister (Narendra Modi) has got an agenda of 2025 for the eradication of tub…
PTI
1 min read
COVID-19 vaccine in India: Expert panel to review Pfizer, Serum and Bharat Biotech's emergency use application tomorrow
The Indian arm of US pharmaceutical giant Pfizer had on December 4 sought approval for its va…
PTI
5 mins read
Here's the data we have so far on the Omicron variant versus our vaccines — what scientists have found, and what remains unanswered
The first lab findings are flying in from scientists around the world. Here's what we know so far o…
Andrew Dunn,Dr. Catherine Schuster-Bruce
2 mins read
EQRx has a bold strategy to disrupt biotech
These are Insider's biggest healthcare stories for August 24.
Shelby Livingston
2 mins read
Expert committee recommends Bharat Biotech’s Covaxin for kids aged between 2-18 years
According to media reports, the Hyderabad-based Bharat Biotech had successfully completed its Ph…
3 mins read
The FDA just fully approved Pfizer's COVID-19 vaccine in a move that could lead to more vaccinations
The shift from emergency use to full approval for the Pfizer-BioNTech shot could spur more people t…
Andrew Dunn
3 mins read
The FDA will allow COVID-19 booster shots for some people with weakened immune systems
The agency's tweak to the emergency OK for COVID-19 vaccines will allow for booster shots for immun…
Andrew Dunn,Cheryl Teh
2 mins read
An Indian COVID-19 vaccine made by Bharat Biotech is set to enter human trials
India, on Monday (June 29) got the approval for conducting human trials of a potential coronavirus …
2 mins read
Zydus Cadila begins human clinical trials of COVID-19 vaccine candidate
The adaptive phase I/ II human clinical trials of ZyCoV-D have commenced with the first human d…
PTI
4 mins read
Men fill more than 9 in 10 biopharma CEO positions, an inequity that costs women more than $500 million in pay each year
Despite more attention being paid to diversity efforts, 92% of top biopharma CEOs are men, an Insid…
Shelby Livingston,Andrew Dunn
3 mins read
Novavax says its coronavirus vaccine was 90% effective in a large trial, moving the shot a step closer to widespread use
Novavax fell behind rivals like Pfizer and Moderna, and the biotech's launch timeline remains hazy.
Andrew Dunn
1 min read
WHO alert against use of Indian cough syrups in Uzbekistan
The World Health Organization on Thursday warned against the use of two Indian cough syrups for chi…
2 mins read
KemPharm skyrockets 90% after FDA approval of ADHD treatment
KemPharm stock skyrocketed on Wednesday after the FDA approved the company's once-daily treatment f…
Will Daniel
2 mins read
Inovio tanks 39% after pausing coronavirus vaccine trial, trading halted
Inovio said its trial is on hold until it answers questions from the Food and Drug Administration, …
Ben Winck
2 mins read
Pfizer seeks emergency use authorisation for its COVID-19 vaccine in India
"Pfizer India has submitted an application on December 4 to the DCGI seeking emergency use au…